Jeff Aronin Works To Help Real People Receive The Drugs They Need To Improve Their Lives

Jeff Aronin is the Chief Executive Officer and Chairman of Paragon Biosciences and has been so since 2010. Paragon is a worldwide healthcare development and biopharmaceutical investment firm that helps biotechnology companies that make people’s lives better to get off of the ground. Aronin has also served as chairman of a spread of companies in the portfolio of Paragon, and a couple of these include Harmony Biosciences and Castle Creek Pharmaceuticals. At Paragon Biosciences, Aronin’s focus, as well as the focus of the rest of the company, is the needs of patients and also to get to the bottom of the science that could help to unravel many diseases that do not have a cure as of yet. the company accomplishes these goals by helping other companies to accomplish theirs. Through these partnerships, drugs that can help people to get their lives back can be developed and put into the hands of the people who need them the most.

Before working with Paragon Biosciences, Jeff Aronin served as the CEO and President of Ovation Pharmaceuticals Inc., which is a company he started in 2000 that focuses on biopharmaceuticals. The company was bought out by Lundceck, Inc. in 2009, and after this, Aronin stayed on as the CEO and President of Lundbeck, Inc. as the transition took place. He has also been the CEO of other biopharmaceutical companies that have done business all over the world, and he has helped many companies with their marketing and finance. He has also been a part of different mergers and acquisitions as well as executing corporate transitions.

 

Through the experienced leadership of Jeff Aronin, Paragon Biosciences has been able to get 13 new medicines approved by studying the needs of patients at a deep level. The company follows a three-pronged process that starts out with a deeper look at the precise needs of a group of patients. They will then build and support companies that can meet the needs of these patients as a part of the second step of the process. The third step involves developing the drugs that can help these people and will continue to help them to make a better life for themselves.